Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Niti Aayog to bring...

    Niti Aayog to bring blockchain technology for drug industry

    Written by Ruby Khatun Khatun Published On 2018-08-04T15:30:33+05:30  |  Updated On 4 Aug 2018 3:30 PM IST
    Niti Aayog to bring blockchain technology for drug industry

    HYDERABAD: Niti Aayog is working with Apollo Hospitals and information technology major Oracle on applying blockchain (decentralized) technology in pharmaceutical supply chain management to detect spurious drugs, Chief Executive Officer of NITI Aayog Amitabh Kant said here on Friday.


    Addressing a gathering through video-conferencing at the inaugural session of International Blockchain Congress 2018 for which Niti Aayog was a co-host, Kant said the organization was working on applying the blockchain technology to pressing problems of the country in areas such as land registry, health records, and fertilizer subsidy distribution m among others.


    "There is a need to use blockchain to track and trace medicines and spurious drugs. Therefore, Niti Aayog, in collaboration with Apollo Hospitals and Oracle, is putting pharmaceutical supply chain in blockchain for complete traceability of drugs from manufacturer to consumer to protect our citizens from the menace of spurious medicines," he said.


    The agency was working with judiciary too to see the civil cases related to land registration and mutation were expedited, he added.


    "The government has to play a leading role in allowing the application of blockchain technology. As the government, we need to make it easier to apply blockchain in pressing areas such as disbursement, land records, health records. Countries around the world had to improve and change the legal system to make themselves use blockchain technology," Kant said.


    Emerging technologies such as blockchain technology were key drivers for ease of doing business and were essential for a free market, he added.


    State Minister for IT and Industries KT Ramarao, Tech Mahindra Chief Executive Officer CP Gurnani and CEO of Nucleus Vision Abhishek Pitti also spoke.


    The valedictory function of the International Blockchain Congress would be held in Goa on August 5.

    Abhishek PittiAmitabh KantApollo HospitalsBlockchainCollaborationCP Gurnanidecentralizeddrug industryKT RamaraomutationNiti AayogNucleus VisionOraclepharmaceutical supply chain managementspurious drugstechTech Mahindraworking
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok